Abbott Laboratories stock holds steady as a defensive health care name

Abbott Laboratories (ISIN US0028241000) is a diversified health care company with a broad mix of diagnostics, medical devices, nutrition, and established pharmaceuticals. The company trades on the New York Stock Exchange under the ticker ABT and remains a large-cap member of the S&P 500.

Business mix

Abbott's scale is part of the story for investors. Diagnostics and medical devices give the company recurring exposure to hospitals, clinics, and long-duration care trends, while nutrition adds a separate consumer health stream.

That mix helps explain why Abbott is often treated as a steadier health care holding than more narrowly focused peers. The company's revenue base is structurally more diversified than a single-product medtech or pure diagnostics name.

Market position

Abbott's U.S. listing and index membership make it a familiar name for American retail investors. The stock's appeal comes from its combination of defensive characteristics and exposure to global health care demand.

For investors, the key question is not one headline catalyst but the durability of the portfolio. A company with multiple operating segments can offset weakness in one area with strength in another.

Representative product

FreeStyle Libre is one of Abbott's best-known products and remains central to the company's diabetes care franchise. The system has helped make Abbott a major player in continuous glucose monitoring.

Stock context

Abbott Laboratories stock trades on the NYSE as ABT. As of July 13, 2026, 10:54 a.m. ET, the shares last changed hands at $0.00 USD.